New Additions

	Pathway May Provide Target For Treating Chronic Pain
	Progenics and Wyeth Announce FDA has Approved Relistor First Drug for Opioid-Induced Constipation to Launch in United States
	The use of ketamine as adjuvant therapy to control severe pain
	The safety and tolerability of the fentanyl HCl iontophoretic transdermal system: an alternative to currently available analgesic modalities
	Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
	Can Coenzyme Q reduce pain?
	Effect of coenzyme q10 on myopathic symptoms in patients treated with statins

Prior Additions

	Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects
	Roxro Pharma's Novel Intranasal Analgesic Provides Effective Pain Relief, New Data Show
	Intrathecal ziconotide for refractory chronic pain
	ZARS Pharma Announces FDA Approval of a Topical Local Anesthetic Peel (Lidocaine and Tetracaine) 7%/7%
	Dexmedetomidine: A Novel Analgesic with Palliative Medicine Potential
	Corgentech's anaesthetic shows positive results in late-stage trial
	Pregabalin: A New Neuromodulator with Broad Therapeutic Indications
	Boehringer Ingelheim and Biolipox Sign Agreement on a New Class of Drugs to Treat Pain and Inflammation
	Medical Marijuana and the Supreme Court (New England Journal of Medicine, August 18, 2005)
	Applied nanotechnology for the management of breakthrough cancer pain
	New topical pain cream, Maxilene, eases procedural pain
	Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial (can download full article)
	Tiagabine and Gabapentin for the Management of Chronic Pain
	The "pain pen" for breakthrough cancer pain: a promising treatment
	Antidepressants and antiepileptic drugs for chronic non-cancer pain
	Elan Receives FDA Approval for PRIALT -Ziconotide Intrathecal Infusion- for Severe Chronic Pain
	Ziconotide is a novel non-opioid, non local anesthetic, developed for the treatment of severe chronic pain
	Intranasal Nicotine for Postoperative Pain Treatment
	Tetrodotoxin Is Safe and Effective for Severe, Refractory Cancer Pain (pdf)
	Clinical Status of Methylnaltrexone, A New Agent to Prevent and Manage Opioid-Induced Side Effects
	Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain
	Role of Pituitary Radiosurgery for the Management of Intractable Pain and Potential Future Applications Conclusion: Our clinical study protocol is only preliminary. Further clinical results on the management of thalamic pain are required to develop this treatment protocol. However, efficacy and safety have been shown in all our cases. In our opinion, this treatment has a potential to control severe pain, and GKS will play an important role in the management of intractable pain.
	Can Marijuana Relieve Pain?
	Marijuana: Adverse Effects
	Cannabinoids for pain and nausea
	Are cannabinoids an effective and safe treatment option in the management of pain?
	The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain Eur J Pharmacol 2003 Jan 24;460(2-3):109-16
	Safety and pharmacokinetics of reN1869: a first human dose study in healthy subjects after single-dose administration All together, it makes ReN1869 a potential new drug candidate for the treatment of chronic pain and inflammatory conditions of neurogenic origin.
	Double blind randomized controlled trial of topical glyceryl trinitrate in anal fissure